ORA BIOMEDICAL: ACCELERATING DRUG DISCOVERY FOR GEROSCIENCE
Michael Muir, Benjamin Blue, Matt Kaeberlein, Mitchell Lee · 2024
Read ORA BIOMEDICAL: ACCELERATING DRUG DISCOVERY FOR GEROSCIENCE by Michael Muir, Benjamin Blue, Matt Kaeberlein, Mitchell Lee (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11690787.txt.
Description
Michael Muir, Benjamin Blue, Matt Kaeberlein, and Mitchell Lee published a company profile in 2024 on Ora Biomedical, a firm speeding drug discovery for aging science. Few aging interventions are ready for clinical work despite a fast-growing sector. The company, spun out of a university lab, screens natural products, drugs, mixtures, and biologics for effects on aging.
Its WormBot-AI platform joins robotics, AI, and tiny worms to test lifespan and health at high volume. A crowd-funded Million Molecule Challenge opens its data to scientists in over twenty countries through a public dashboard. The authors invite academic and industry partners for screening services across disease and mutant models.
Catalog record
| CREATOR | Michael Muir, Benjamin Blue, Matt Kaeberlein, Mitchell Lee |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |